ARCHIVES

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

This article is from The Cancer Letter archive.

Vol. 39 No. 07 | February 15, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Meetings Listed

October 24, 1997

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

NSABP Accrual Slow, But Auditing Called “Impressive”

January 20, 1995

More Control Project Plans, Future RPs Listed

November 15, 1974

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986